$ABEO
ABEONA THERAPEUTICS INC.

2018 Q2 Form 10-Q Financial Statement

#000114420418027209 Filed on May 10, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2018 Q1 2017 Q1
Revenue $819.0K $531.0K $186.0K
YoY Change 277.42% 185.48% -22.5%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.630M $2.880M $3.020M
YoY Change 75.38% -4.64% -30.89%
% of Gross Profit
Research & Development $7.916M $8.162M $2.198M
YoY Change 36.29% 271.34% 18.17%
% of Gross Profit
Depreciation & Amortization $290.0K $174.0K $250.0K
YoY Change 40.1% -30.4% 47.06%
% of Gross Profit
Operating Expenses $7.916M $8.162M $2.198M
YoY Change 36.29% 271.34% -65.66%
Operating Profit -$12.56M -$10.68M -$5.284M
YoY Change 48.78% 102.18%
Interest Expense $310.0K $150.0K $40.00K
YoY Change 93.75% 275.0% -93.55%
% of Operating Profit
Other Income/Expense, Net $314.0K $153.0K $37.00K
YoY Change 95.03% 313.51%
Pretax Income -$12.24M -$10.53M -$5.250M
YoY Change 47.83% 100.57% -5.23%
Income Tax
% Of Pretax Income
Net Earnings -$12.24M -$10.53M -$5.247M
YoY Change 47.88% 100.69% -5.29%
Net Earnings / Revenue -1494.87% -1983.05% -2820.97%
Basic Earnings Per Share
Diluted Earnings Per Share -$258.8K -$223.8K -$130.4K
COMMON SHARES
Basic Shares Outstanding 47.31M shares 47.23M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q2 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $119.8M $132.0M $63.20M
YoY Change 105.49% 108.86% 68.98%
Cash & Equivalents $49.99M $132.0M $63.21M
Short-Term Investments $69.90M
Other Short-Term Assets $1.900M $2.100M $500.0K
YoY Change 111.11% 320.0% 150.0%
Inventory
Prepaid Expenses
Receivables $0.00 $100.0K $100.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $121.8M $134.2M $63.80M
YoY Change 105.44% 110.27% 68.78%
LONG-TERM ASSETS
Property, Plant & Equipment $8.007M $4.789M $700.0K
YoY Change 1043.86% 584.14% 40.0%
Goodwill $32.47M $32.47M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $600.0K $400.0K $100.0K
YoY Change 500.0% 300.0% 0.0%
Total Long-Term Assets $44.87M $41.50M $41.50M
YoY Change 20.11% 0.0% 4.8%
TOTAL ASSETS
Total Short-Term Assets $121.8M $134.2M $63.80M
Total Long-Term Assets $44.87M $41.50M $41.50M
Total Assets $166.7M $175.7M $105.3M
YoY Change 72.46% 66.81% 36.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.783M $5.910M $1.500M
YoY Change 59.88% 294.0% 50.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.783M $2.393M $6.100M
YoY Change 37.07% -60.77% -19.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00 $3.500M
YoY Change -100.0% -100.0% -14.63%
Total Long-Term Liabilities $0.00 $0.00 $3.500M
YoY Change -100.0% -100.0% -14.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.783M $2.393M $6.100M
Total Long-Term Liabilities $0.00 $0.00 $3.500M
Total Liabilities $5.783M $2.393M $9.600M
YoY Change -23.72% -75.07% -18.64%
SHAREHOLDERS EQUITY
Retained Earnings -$376.3M -$353.5M
YoY Change 8.76%
Common Stock $537.2M $533.8M
YoY Change 23.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $160.9M $169.7M $95.71M
YoY Change
Total Liabilities & Shareholders Equity $166.7M $175.7M $105.3M
YoY Change 72.46% 66.81% 36.05%

Cashflow Statement

Concept 2018 Q2 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income -$12.24M -$10.53M -$5.247M
YoY Change 47.88% 100.69% -5.29%
Depreciation, Depletion And Amortization $290.0K $174.0K $250.0K
YoY Change 40.1% -30.4% 47.06%
Cash From Operating Activities -$9.020M -$4.082M -$5.857M
YoY Change 81.12% -30.31% 132.42%
INVESTING ACTIVITIES
Capital Expenditures -$3.420M $3.502M $74.00K
YoY Change 34100.0% 4632.43% -132.17%
Acquisitions
YoY Change
Other Investing Activities -$69.85M $0.00
YoY Change
Cash From Investing Activities -$73.28M -$3.502M -$74.00K
YoY Change 732700.0% 4632.43% -67.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 570.0K 1.829M $1.000K
YoY Change 533.33% 182800.0%
NET CHANGE
Cash From Operating Activities -9.020M -4.082M -$5.857M
Cash From Investing Activities -73.28M -3.502M -$74.00K
Cash From Financing Activities 570.0K 1.829M $1.000K
Net Change In Cash -81.73M -5.755M -$5.930M
YoY Change 1567.96% -2.95% 115.64%
FREE CASH FLOW
Cash From Operating Activities -$9.020M -$4.082M -$5.857M
Capital Expenditures -$3.420M $3.502M $74.00K
Free Cash Flow -$5.600M -$7.584M -$5.931M
YoY Change 12.68% 27.87% 159.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1374000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3977000 USD
CY2017Q4 us-gaap Goodwill
Goodwill
32466000 USD
CY2018Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2018Q1 dei Entity Registrant Name
EntityRegistrantName
ABEONA THERAPEUTICS INC.
CY2018Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000318306
CY2018Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2018Q1 dei Trading Symbol
TradingSymbol
ABEO
CY2018Q1 dei Amendment Flag
AmendmentFlag
false
CY2018Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47305285 shares
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
131995000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137750000 USD
CY2018Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
64000 USD
CY2017Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
107000 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2735000 USD
CY2018Q1 us-gaap Assets Current
AssetsCurrent
134151000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
140592000 USD
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4789000 USD
CY2018Q1 dei Document Type
DocumentType
10-Q
CY2018Q1 dei Document Period End Date
DocumentPeriodEndDate
2018-03-31
CY2018Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2092000 USD
CY2018Q1 us-gaap Goodwill
Goodwill
32466000 USD
CY2018Q1 us-gaap Assets
Assets
175653000 USD
CY2017Q4 us-gaap Assets
Assets
178766000 USD
CY2018Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5910000 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2393000 USD
CY2018Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
544000 USD
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3214000 USD
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6454000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5607000 USD
CY2018Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0 USD
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
153000 USD
CY2017Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3061000 USD
CY2018Q1 us-gaap Liabilities
Liabilities
6454000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
8668000 USD
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
472000 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
469000 USD
CY2018Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
533319000 USD
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
529421000 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-364592000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-359792000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
169199000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
170098000 USD
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
175653000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
178766000 USD
CY2018Q1 us-gaap Licenses Revenue
LicensesRevenue
0 USD
CY2017Q1 us-gaap Licenses Revenue
LicensesRevenue
151000 USD
CY2018Q1 us-gaap Royalty Revenue
RoyaltyRevenue
50000 USD
CY2017Q1 us-gaap Royalty Revenue
RoyaltyRevenue
35000 USD
CY2018Q1 us-gaap Sales Revenue Net
SalesRevenueNet
2598000 USD
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
186000 USD
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8162000 USD
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2198000 USD
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2878000 USD
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3022000 USD
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
174000 USD
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
250000 USD
CY2018Q1 us-gaap Costs And Expenses
CostsAndExpenses
11214000 USD
CY2017Q1 us-gaap Costs And Expenses
CostsAndExpenses
5470000 USD
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8616000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5284000 USD
CY2018Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
156000 USD
CY2017Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
39000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-8463000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-5247000 USD
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47060523 shares
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40254679 shares
CY2018Q1 abeo Interest And Other Expense
InterestAndOtherExpense
3000 USD
CY2017Q1 abeo Interest And Other Expense
InterestAndOtherExpense
2000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1685000 USD
CY2018Q1 abeo Stock Issued During Period Value Warrants Two Exercised
StockIssuedDuringPeriodValueWarrantsTwoExercised
144000 USD
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1900000 USD
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1492000 USD
CY2018Q1 abeo Allocated Share Based Compensation Expense Restricted Stock
AllocatedShareBasedCompensationExpenseRestrictedStock
172000 USD
CY2017Q1 abeo Allocated Share Based Compensation Expense Restricted Stock
AllocatedShareBasedCompensationExpenseRestrictedStock
362000 USD
CY2018Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-43000 USD
CY2017Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
24000 USD
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-643000 USD
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
308000 USD
CY2018Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2068000 USD
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-151000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4082000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5857000 USD
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3502000 USD
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
74000 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3502000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-74000 USD
CY2018Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1685000 USD
CY2017Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1829000 USD
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1000 USD
CY2018Q1 abeo Other Assets And Restricted Cash
OtherAssetsAndRestrictedCash
357000 USD
CY2017Q4 abeo Other Assets And Restricted Cash
OtherAssetsAndRestrictedCash
357000 USD
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
37000 USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47232940 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46888108 shares
CY2018Q1 us-gaap Revenue From Grants
RevenueFromGrants
2548000 USD
CY2017Q1 us-gaap Revenue From Grants
RevenueFromGrants
0 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1900000 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
172000 USD
CY2018Q1 us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
3663000 USD
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
3000 USD
CY2017Q1 us-gaap Interest Paid Net
InterestPaidNet
2000 USD
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3517000 USD
CY2017Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2231000 USD
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5755000 USD
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5930000 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
346000 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
346000 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2247000 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3890000 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
259000 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
346000 USD
CY2018Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
346000 USD
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
87000 USD
CY2017Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
203000 USD
CY2018Q1 us-gaap Other Commitment
OtherCommitment
1456000 USD
CY2018Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2612000 USD
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2612000 USD
CY2018Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0 USD
CY2018Q1 us-gaap Liabilities
Liabilities
5005000 USD
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-356129000 USD
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
170098000 USD
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
132275000 USD
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
63212000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
138030000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69142000 USD
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
63212000 USD
CY2018Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
280000 USD
CY2017Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 USD
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0237 pure
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.83
CY2018Q1 abeo Sharebased Compensation Arrangement By Sharebased Payment Award Option Grants In Period Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionGrantsInPeriodWeightedAverageGrantDateFairValue
10.83 USD
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
13.72
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
0 USD
CY2018Q1 us-gaap Grants Receivable
GrantsReceivable
13850000 USD
CY2018Q1 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
2600000 USD
CY2017Q4 abeo Proceeds From Grant Received
ProceedsFromGrantReceived
3100000 USD
CY2017Q4 abeo Proceeds From Grant Received
ProceedsFromGrantReceived
2600000 USD
CY2018Q1 abeo Proceeds From Grant Received
ProceedsFromGrantReceived
500000 USD
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.0109 pure

Files In Submission

Name View Source Status
0001144204-18-027209-index-headers.html Edgar Link pending
0001144204-18-027209-index.html Edgar Link pending
0001144204-18-027209.txt Edgar Link pending
0001144204-18-027209-xbrl.zip Edgar Link pending
abeo-20180331.xml Edgar Link completed
abeo-20180331.xsd Edgar Link pending
abeo-20180331_cal.xml Edgar Link unprocessable
abeo-20180331_def.xml Edgar Link unprocessable
abeo-20180331_lab.xml Edgar Link unprocessable
abeo-20180331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv493214_10q.htm Edgar Link pending
tv493214_ex10-1.htm Edgar Link pending
tv493214_ex31-1.htm Edgar Link pending
tv493214_ex31-2.htm Edgar Link pending
tv493214_ex32-1.htm Edgar Link pending
tv493214_ex32-2.htm Edgar Link pending